findmyKOL
Clinical trialNCT04177953CompletedPhase 2Interventional

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

SponsorInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestEnrollment92Pleural Mesothelioma Malignant
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Rajiv Shah, MD

    Thoraxklinik Heidelberg gGmbH, Medizinische Onkologie - Universitätsklinikum Heidelberg

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Vivantes Klinikum Neukölln, Klinik Für Hämatologie, Onkologie Und Palliativmedizin

    Berlin, Germany

  • Klinikum Bremen Ost Pneumologie Und Beatmungsmedizin

    Bremen, Germany

  • Studienzentrum Der Thorachirurgischen Und Pneumologischen Klinik Klinken Der Stadt Köln Ggmbh Krankenhaus Merheim

    Cologne, Germany

  • Ev. Kliniken Essen-Mitte, Klinik Für Internistische Onkologie

    Essen, Germany

  • Universitätsklinikum Freiburg Klinik Für Innere Medizin I

    Freiburg im Breisgau, Germany

  • Asklepios Fachklinik München-Gauting Thorakale Onkologie

    Gauting, Germany

  • Lungenclinic Grosshansdorf

    Großhansdorf, Germany

  • Asklepios Klinikum Harburg, Klinik Für Lungen-, Thorax Und Atemwegserkrankungen

    Harburg, Germany

  • Thoraxklinik Heidelberg Ggmbh, Medizinische Onkologie

    Heidelberg, Germany

  • Lungenklinik Hemer, Pneumologie Und Thorakale Onkologie

    Hemer, Germany

  • Universitätsklinikum Regensburg, Thoraxchirurgie

    Regensburg, Germany

  • Robert-Bosch-Krankenhaus - Klinik Schillerhöhe, Onkologie

    Stuttgart, Germany

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Feb 2019
Primary completion
30 Jan 2025
Completion
30 Jan 2025
Last update posted
6 Feb 2025
Registered enrollment
92
Registry id
NCT04177953

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.